Pilot Study of Therapy With Hylan G-F 20 Exercise Capacity

PHASE1TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Knee Osteoarthritis
Interventions
DEVICE

Hylan G-F 20

"Synvisc is an elastoviscous high molecular weight fluid which is injected into the knee joint (intra-articular) for relief of pain from osteoarthritis in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics."

OTHER

Control

Control is puncture of the skin at the site of the knee.

Trial Locations (1)

43214

McConnell Heart Health Center, Columbus

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

OhioHealth

OTHER